Anti-GGT5/ GGL/ GGT 5 monoclonal antibody

Anti-GGT5/ GGL/ GGT 5 antibody for FACS & in-vivo assay

Target products collectionGo to GGT5/GGT5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0481-Ab-1/ GM-Tg-hg-MP0481-Ab-2Anti-Human GGT5 monoclonal antibodyHuman
GM-Tg-rg-MP0481-Ab-1/ GM-Tg-rg-MP0481-Ab-2Anti-Rat GGT5 monoclonal antibodyRat
GM-Tg-mg-MP0481-Ab-1/ GM-Tg-mg-MP0481-Ab-2Anti-Mouse GGT5 monoclonal antibodyMouse
GM-Tg-cynog-MP0481-Ab-1/ GM-Tg-cynog-MP0481-Ab-2Anti-Cynomolgus/ Rhesus macaque GGT5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0481-Ab-1/ GM-Tg-felg-MP0481-Ab-2Anti-Feline GGT5 monoclonal antibodyFeline
GM-Tg-cang-MP0481-Ab-1/ GM-Tg-cang-MP0481-Ab-2Anti-Canine GGT5 monoclonal antibodyCanine
GM-Tg-bovg-MP0481-Ab-1/ GM-Tg-bovg-MP0481-Ab-2Anti-Bovine GGT5 monoclonal antibodyBovine
GM-Tg-equg-MP0481-Ab-1/ GM-Tg-equg-MP0481-Ab-2Anti-Equine GGT5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0481-Ab-1/ GM-Tg-hg-MP0481-Ab-2; GM-Tg-rg-MP0481-Ab-1/ GM-Tg-rg-MP0481-Ab-2;
GM-Tg-mg-MP0481-Ab-1/ GM-Tg-mg-MP0481-Ab-2; GM-Tg-cynog-MP0481-Ab-1/ GM-Tg-cynog-MP0481-Ab-2;
GM-Tg-felg-MP0481-Ab-1/ GM-Tg-felg-MP0481-Ab-2; GM-Tg-cang-MP0481-Ab-1/ GM-Tg-cang-MP0481-Ab-2;
GM-Tg-bovg-MP0481-Ab-1/ GM-Tg-bovg-MP0481-Ab-2; GM-Tg-equg-MP0481-Ab-1/ GM-Tg-equg-MP0481-Ab-2
Products NameAnti-GGT5 monoclonal antibody
Formatmab
Target NameGGT5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GGT5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GGT5/ GGL/ GGT 5 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0481
    Target NameGGT5
    Gene ID2687,23887,29566,486401,101082015,787326,100050259
    Gene Symbol and SynonymsGGL,GGT 5,GGT-REL,GGT5,Ggta1,GGTLA1
    Uniprot AccessionP36269,Q9QWE9
    Uniprot Entry NameGGT5_HUMAN,GGT5_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000099998
    Target ClassificationN/A

    The target: GGT5, gene name: GGT5, also named as GGL, GGT 5, GGT-REL, GGTLA1. This gene is a member of the gamma-glutamyl transpeptidase gene family, and some reports indicate that it is capable of cleaving the gamma-glutamyl moiety of glutathione. The protein encoded by this gene is synthesized as a single, catalytically-inactive polypeptide, that is processed post-transcriptionally to form a heavy and light subunit, with the catalytic activity contained within the small subunit. The encoded enzyme is able to convert leukotriene C4 to leukotriene D4, but appears to have distinct substrate specificity compared to gamma-glutamyl transpeptidase. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.